Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Multiple myeloma metabolism – a treasure trove of therapeutic targets?

Journal article

Roman-Trufero M. et al, (2022), Frontiers in immunology, 13

Editorial - Cancer and Bone special issue.

Journal article

Edwards CM. and Drake MT., (2022), Bone, 158

Myeloma and marrow adiposity: Unanswered questions and future directions.

Journal article

Morris EV. and Edwards CM., (2021), Best pract res clin endocrinol metab, 35

Advances in the molecular pharmacology of bone and cancer-related bone diseases.

Journal article

Edwards CM. and Russell RGG., (2021), Br j pharmacol, 178, 1889 - 1890

Morphogens and growth factor signalling in the myeloma bone-lining niche.

Journal article

Morris EV. and Edwards CM., (2021), Cell mol life sci

Biological relationship between bone and myeloma cells

Chapter

Edwards CM. and Lawson MA., (2021), Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside, 1005 - 1017

Myeloma Cells Down-Regulate Adiponectin in Bone Marrow Adipocytes Via TNF-Alpha.

Journal article

Morris EV. et al, (2020), J bone miner res, 35, 942 - 955

Cholesterol promotes myeloma cell viability and increases bone marrow myeloma tumour burden in vivo

Conference paper

Beatriz G. et al, (2019), Journal of bone and mineral research, 34, 198 - 198

Cholesterol promotes myeloma cell viability and increases bone marrow myeloma tumour burden in vivo

Conference paper

Beatriz G. et al, (2019), Journal of bone and mineral research, 34, 198 - 198

Pretreatment with the antidiabetic drug metformin alters the bone microenvironment to increase myeloma tumour burden and bone disease in vivo

Conference paper

Gamez B. et al, (2019), Journal of bone and mineral research, 34, 197 - 197

Pretreatment with the antidiabetic drug metformin alters the bone microenvironment to increase myeloma tumour burden and bone disease in vivo

Conference paper

Gamez B. et al, (2019), Journal of bone and mineral research, 34, 197 - 197

Load More